Australia markets closed

  • ALL ORDS

    7,270.00
    +3.40 (+0.05%)
     

  • ASX 200

    7,068.80
    +3.60 (+0.05%)
     

  • AUD/USD

    0.6443
    +0.0026 (+0.40%)
     

  • OIL

    90.33
    +0.70 (+0.78%)
     

  • GOLD

    1,944.90
    +5.30 (+0.27%)
     

  • Bitcoin AUD

    41,221.74
    -100.41 (-0.24%)
     

  • CMC Crypto 200

    565.87
    -2.18 (-0.38%)
     

  • AUD/EUR

    0.6049
    +0.0036 (+0.60%)
     

  • AUD/NZD

    1.0810
    -0.0001 (-0.01%)
     

  • NZX 50

    11,372.62
    +53.88 (+0.48%)
     

  • NASDAQ

    14,701.10
    +6.85 (+0.05%)
     

  • FTSE

    7,683.91
    +5.29 (+0.07%)
     

  • Dow Jones

    33,963.84
    -106.58 (-0.31%)
     

  • DAX

    15,557.29
    -14.57 (-0.09%)
     

  • Hang Seng

    18,057.45
    +402.04 (+2.28%)
     

  • NIKKEI 225

    32,402.41
    -168.62 (-0.52%)
     
FEELING THE PINCH? :

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Company News for Aug 24, 2022

Zacks Equity Research
·1-min read

  • Shares of JD.com, Inc. JD jumped 3.4% after posting second-quarter 2022 earnings of $0.61 per share, surpassing the Zacks Consensus Estimate of $0.46 per share.

  • Shares of Healthpeak Properties, Inc. PEAK dropped 3.2% at weak housing sales data.

  • Twitter, Inc.’s TWTR shares plunged 7.3% after its former head of security made accusations about the company making false statements about its security practices and lying to Elon Musk about fake accounts on its platform.

  • Shares of Macy’s, Inc. M jumped 3.8% after posting second-quarter 2022 earnings of $1 per share, beating the Zacks Consensus Estimate of $0.85 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Macy's, Inc. (M) : Free Stock Analysis Report

Twitter, Inc. (TWTR) : Free Stock Analysis Report

JD.com, Inc. (JD) : Free Stock Analysis Report

Healthpeak Properties, Inc. (PEAK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research